Bexsero MenB
Selected indexed studies
- 4CMenB journey to the 10-year anniversary and beyond. (Hum Vaccin Immunother, 2024) [PMID:38976659]
- Bexsero® chronicle. (Pathog Glob Health, 2014) [PMID:25417906]
- Meningococcal Vaccinations. (Infect Dis Ther, 2016) [PMID:27086142]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- 4CMenB journey to the 10-year anniversary and beyond. (2024) pubmed
- Bexsero® chronicle. (2014) pubmed
- Meningococcal Vaccinations. (2016) pubmed
- The introduction of the meningococcal B (MenB) vaccine (Bexsero®) into the national infant immunisation programme--New challenges for public health. (2015) pubmed
- Health impact and cost-effectiveness of introducing the vaccine (Bexsero) against MenB disease into the Brazilian immunization programme. (2019) pubmed
- MenB (Bexsero) immunisation side effects in extremely premature infants (<28 weeks). (2018) pubmed
- Timing of meningococcal vaccination with 4CMenB (Bexsero®) in children with invasive meningococcal group B (MenB) disease in England. (2022) pubmed
- New Dosing Interval and Schedule for the Bexsero MenB-4C Vaccine: Updated Recommendations of the Advisory Committee on Immunization Practices - United States, October 2024. (2024) pubmed
- Clinical experience with the meningococcal B vaccine, Bexsero(®): Prospects for reducing the burden of meningococcal serogroup B disease. (2016) pubmed
- First use of Trumenba (MenB-fHbp) vaccine to control a nursery outbreak of serogroup B invasive meningococcal disease involving children previously immunised with Bexsero (4CMenB), England, November 2023. (2026) pubmed